Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phio Pharmaceuticals Corp shares valued at $740 were purchased by Bitterman Robert J on Jun 07 ’24. At $0.74 per share, Bitterman Robert J acquired 1,000 shares. The insider’s holdings grew to 20,990 shares worth approximately $42819.6 following the completion of this transaction.
Also, Bitterman Robert J purchased 1,000 shares, netting a total of over 750 in proceeds. Following the buying of shares at $0.75 each, the insider now holds 19,990 shares.
As published in their initiating research note from H.C. Wainwright on August 05, 2020, Phio Pharmaceuticals Corp [PHIO] has been a Buy and the price target has been revised to $4.
Analyzing PHIO Stock Performance
During the last five days, there has been a surge of approximately 6.25%. Over the course of the year, Phio Pharmaceuticals Corp shares have jumped approximately 13.33%. Shares of the company reached a 52-week high of $9.7900 on 01/13/25 and a 52-week low of $0.9700 on 04/08/25. A 50-day SMA is recorded $1.6200, while a 200-day SMA reached $2.4500.
Support And Resistance Levels for Phio Pharmaceuticals Corp (PHIO)
According to the 24-hour chart, there is a support level at 1.8100, which, if violated, would cause prices to drop to 1.5900. In the upper region, resistance lies at 2.2100. The next price resistance is at 2.3900. RSI (Relative Strength Index) is 53.65 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2600, which suggests the price will decrease in the coming days. Percent R is at 73.71%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
